|
Management Of Bladder High Grade Superficial Tumors About 40 Cases
[Full Text]
AUTHOR(S)
Y. Essatara, M. H. Benazzouz, A. Mazdar H. El Sayegh, A. Iken, L. Benslimane, Y. Nouini.
KEYWORDS
Index Terms: Urology,tumors,bladder,superficial,Pt1G3
ABSTRACT
Abstracts: non-invasive Urothelial bladder tumors constitute a group with a common first-line conservative treatment and a high risk of recurrence, which requires systematic monitoring. We undertook this work in a retrospective descriptive study, including 40 patients having been treated in the urology department for A class T1G3 urothelial carcinoma.
REFERENCES
[1] K. Bensalah, J.-J. Patard: Prise en charge des tumeurs de vessie T1G3, EMC UROLOGIE, 18-244-A-13, 2006
[2] Delphine Amsellem-Ouazana, francois goldwasser, Ivan Bieche, Rosette Lidereau, Marc Zerbib : therapeutiques ciblees enti ErbB et tumeurs urotheliales Progres en Urologie (2005), 15, Supp. N°1, 1229-1235
[3] F.Ouaki et coll. : le statut initial ou secondaire des tumeurs de vessie T1 G3 a-t-il un impact pronostique? Progres en Urologie (2006), 16, 40-44
[4] J. Rigaud et coll., Progres en Urologie (2002), 12, 27-30
[5] Herr HW..: the value of a second transurethral resection in evaluating patients with bladder tumors.j of u vol. 162,74-76, july 1999
[6] Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE. Primary T1G3 bladder cancer:organ preserving.
|
